AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · New Mexico

SM12

Study Psilocybin For Therapeutic Treatments

Status

Enacted

2024 Session

IntroducedFeb 6, 2024 (done)
PassedDate TBC (done)
SignedDate TBC (done)
Law in effectNext step (current)

Sponsor: Craig Brandt (Republican)
Type: Study/Task Force
Substances: Psilocybin

Official text

Summary (from PoliPsy)

Study Psilocybin For Therapeutic Treatments

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: nmlegis.gov

Legislative history

February 14, 2024
Passed
February 14, 2024
Passed
February 14, 2024
Engrossed (Passed One Chamber)
February 10, 2024
Committee Report
February 6, 2024
Introduced

Loading bill…